Due to crosstalk between the TSC1/TSC2, mTOR, and ELOC pathways, and their overlapping histological and immunohistochemical features, some authors have grouped these tumors under the term “RCC with leiomyomatous stroma”. This evidence concerns the gene TSC1 and renal cell carcinoma.